Literature DB >> 1528388

The pathological evolution of multiple sclerosis.

W I McDonald1, D H Miller, D Barnes.   

Abstract

The new technique of nuclear magnetic resonance imaging (NMR) has been found to have particular value in the study of the evolution of the plaque of multiple sclerosis. Particularly when combined with gadolinium enhancement, the method not only shows very dramatically the waxing and waning of the plaque with time, it also demonstrates with remarkable clarity the important role of changes in vascular permeability in the pathological process. In this Annotation the ability of this technique to throw new light on the process of plaque formation and evaluation is critically assessed. In addition, the role of changing fluid content of the extracellular spaces of the CNS in influencing interpretation of the more conventional clinical and electrophysiological findings is discussed. While the method of NMR analysis does not yet show us how the plaque is initiated, it is suggested that future studies with these new techniques in the living subject may well lead us to rational therapeutic approaches based on pathogenetic mechanisms.

Entities:  

Mesh:

Year:  1992        PMID: 1528388     DOI: 10.1111/j.1365-2990.1992.tb00794.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  32 in total

1.  Diffusion-weighted MR imaging of multiple sclerosis: added clinical value or "just another pretty face?".

Authors:  M H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 3.825

2.  Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging.

Authors:  A C Guo; V L Jewells; J M Provenzale
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

Review 3.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

4.  Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis.

Authors:  A Campi; M Filippi; G Comi; G Scotti; S Gerevini; V Dousset
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

5.  Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.

Authors:  Yong Wang; Peng Sun; Qing Wang; Kathryn Trinkaus; Robert E Schmidt; Robert T Naismith; Anne H Cross; Sheng-Kwei Song
Journal:  Brain       Date:  2015-02-26       Impact factor: 13.501

6.  Supervised automatic procedure to identify new lesions in brain MR longitudinal studies of patients with multiple sclerosis.

Authors:  R C Parodi; F Levrero; M P Sormani; A Pilot; G L Mancardi; A Aliprandi; F Sardanelli
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

7.  Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis.

Authors:  Weiquan Lu; Madhuri Bhasin; Stella E Tsirka
Journal:  J Neurosci       Date:  2002-12-15       Impact factor: 6.167

8.  Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques.

Authors:  D Gambi; T Fulgente; D Melchionda; M Onofrj
Journal:  Ital J Neurol Sci       Date:  1996-02

Review 9.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

10.  Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis.

Authors:  Marco Rovaris; Giancarlo Comi; David Ladkani; Jerry S Wolinsky; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.